Last reviewed · How we verify

NCT07522138: SelfExPD

Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study

Not yet recruiting NA Last updated 15 April 2026
What this trial tests

NA trial testing Home-based self-exercise feedback program using video in Home Exercise Program in 15 participants. Not yet recruiting.

Timeline
20 April 2026
Primary endpoint
1 December 2026
28 February 2027

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date20 April 2026
Primary completion1 December 2026
Estimated completion28 February 2027
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Home Exercise Program or PD - Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Home Exercise Program

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07522138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing